Guardant Health
GH
#1121
Rank
A$29.80 B
Marketcap
A$220.32
Share price
0.16%
Change (1 day)
34.97%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of June 2026 : A$2.88 Billion

According to Guardant Health 's latest financial reports the company's total assets are A$2.88 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$3.00 B25.87%
2024-12-31A$2.38 B-8.91%
2023-12-31A$2.62 B10.83%
2022-12-31A$2.36 B-22.19%
2021-12-31A$3.04 B2.92%
2020-12-31A$2.95 B114.91%
2019-12-31A$1.37 B64.88%
2018-12-31A$0.83 B89.82%
2017-12-31A$0.43 B171.64%
2016-12-31A$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
A$4.99 B 72.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$4.01 B 38.97%๐Ÿ‡บ๐Ÿ‡ธ USA